Form D · Other Technology
Immune Co.
Boston, MA · CIK 0002053263
Offering snapshot reported Feb 3, 2025 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Jan 27, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 3, 2025 | Initial | $1,000,000 | No comparison | 6 | SEC filing |
| Feb 3, 2025 | Initial | $6,399,986 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-537152
Simple Agreement for Future Equity (SAFEs)
Source: Form D, filed Feb 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ariana Thacker | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
867 Boylston St. Suite 500 Mailbox #198
Boston, MA, 02116
Boston, MA, 02116